In our first podcast, we sat down with Chief Scientific Officer Marie Onakomaiya to discuss the principles of behavioral science, why it’s being leveraged in clinical trials, and how it can be used to drive instrument compliance and engagement among clinical trial participants.
In our first podcast, we sat down with Chief Scientific Officer Marie Onakomaiya to discuss the principles of behavioral science, why it’s being leveraged in clinical trials, and how it can be used to drive instrument compliance and engagement among clinical trial participants.